Tech Company Financing Transactions

Veralox Therapeutics Funding Round

Veralox Therapeutics secured a $5.4 million Seed funding round on 9/6/2019. Backers included JDRF T1D Fund, Sanofi-Genzyme BioVentures and Virginia Tech Carilion Innovation Fund.

Transaction Overview

Announced On
9/6/2019
Transaction Type
Venture Equity
Amount
$5,400,000
Round
Seed
Investors

JDRF T1D Fund (Lead Investor) (Katie Ellias)

Sanofi-Genzyme BioVentures (Lead Investor) (Daniel Mansuri)

Virginia Tech Carilion Innovation Fund (Lead Investor)

Maryland Momentum Fund

TEDCO

Proceeds Purpose
With the support of the T1D Fund, Sanofi Ventures, and our other investors, we are well positioned to broaden the potential indications for our technology while ensuring sufficient capital to prepare for clinical studies in patients.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4539 Metropolitan Ct.
Frederick, MD 21704
USA
Email Address
Overview
We are developing first-in-class small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. Based on an understanding of the molecular mechanisms of these diseases, these efforts will lead to new treatment paradigms and better outcomes for patients.
Profile
Veralox Therapeutics LinkedIn Company Profile
Social Media
Veralox Therapeutics Company Twitter Account
Company News
Veralox Therapeutics News
Facebook
Veralox Therapeutics on Facebook
YouTube
Veralox Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Jeffrey Strovel
  Jeffrey Strovel LinkedIn Profile  Jeffrey Strovel Twitter Account  Jeffrey Strovel News  Jeffrey Strovel on Facebook
Chief Medical Officer
Michael Hanna
  Michael Hanna LinkedIn Profile  Michael Hanna Twitter Account  Michael Hanna News  Michael Hanna on Facebook
Chief Operating Officer
Matthew Boxer
  Matthew Boxer LinkedIn Profile  Matthew Boxer Twitter Account  Matthew Boxer News  Matthew Boxer on Facebook
Chief Scientific Officer
David Maloney
  David Maloney LinkedIn Profile  David Maloney Twitter Account  David Maloney News  David Maloney on Facebook
VP - R & D
Michael Holinstat
  Michael Holinstat LinkedIn Profile  Michael Holinstat Twitter Account  Michael Holinstat News  Michael Holinstat on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/5/2019: Clio venture capital transaction
Next: 9/6/2019: Terramera venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary